secwatch / observer
8-K filed February 17, 2026, 6:59 PM ET ticker CHRN CIK 0001549084
M&A confidence high sentiment negative materiality 0.95

Ekso to merge with Applied Digital Cloud in reverse merger; APLD to own ~97%, rename to ChronoScale

EKSO BIONICS HOLDINGS, INC.

Key facts

Extracted from this filing and checked against the source text.

Equity Issuances SEC 8-K Item 3.02/3.03 confidence 0.4

EKSO BIONICS HOLDINGS, INC. issued 138,216,820 newly issued shares of common stock to Contributor.

Security
common stock
Shares
138,216,820 newly issued shares
Purchaser
Contributor
Exact text from the filing
The Exchanged Shares will be issued in a private placement transaction in reliance on the exemption from the registration requirements provided by Rule 506(b) under Regulation D promulgated under the Securities Act.
View on SEC.gov
Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

EKSO BIONICS HOLDINGS, INC.: Board approved Second Restated Articles, effective upon Closing, increasing authorized common shares from 141,428,571 to 290,000,000 and making other changes (effective 2026-02-14).

Change
charter amendment
Effective
2026-02-14
Exact text from the filing
On February 14, 2026, the Board approved the Second Restated Articles, which will only become effective immediately prior to the Closing, subject to stockholder approval, and the Second Amended and Restated Bylaws (the “Second Restated Bylaws”), which will only become effective upon the Closing.
View on SEC.gov
Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

EKSO BIONICS HOLDINGS, INC.: Amendment No. 1 to Bylaws removes prohibition on stockholder action by written consent and revises record date provision to clarify applicability to meetings only (effective 2026-02-14).

Change
bylaw amendment
Effective
2026-02-14
Exact text from the filing
On February 14, 2026, the Board adopted an amendment (“Amendment No. 1”) to the Company’s amended and restated by-laws (the “Bylaws”) to align certain provisions of the Bylaws with Nevada law by (i) removing the provision of the Bylaws prohibiting stockholder action by written consent, and (ii) revising the record date provision to clarify that such provision is only applicable to meetings of stockholders.
View on SEC.gov
Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

EKSO BIONICS HOLDINGS, INC.: Second Restated Bylaws introduce new provisions effective upon Closing, including quorum requirements, written consent rules, board quorum, amendment provisions, and no cumulative voting (effective 2026-02-14).

Change
bylaw amendment
Effective
2026-02-14
Exact text from the filing
On February 14, 2026, the Board approved the Second Restated Articles, which will only become effective immediately prior to the Closing, subject to stockholder approval, and the Second Amended and Restated Bylaws (the “Second Restated Bylaws”), which will only become effective upon the Closing.
View on SEC.gov
Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

EKSO BIONICS HOLDINGS, INC. entered into Contribution and Exchange Agreement with APLD Intermediate HoldCo LLC, APLD ChronoScale HoldCo LLC, and Applied Digital Cloud Corporation (effective 2026-02-15).

Action
entry
Agreement
merger
Counterparty
APLD Intermediate HoldCo LLC, APLD ChronoScale HoldCo LLC, and Applied Digital Cloud Corporation
Effective
2026-02-15
Exact text from the filing
On February 15, 2026, Ekso Bionics Holdings, Inc., a Nevada corporation (“Ekso” or the “Company”), entered into a Contribution and Exchange Agreement (the “Contribution and Exchange Agreement”) with APLD Intermediate HoldCo LLC, a Delaware limited liability company (“APLD Intermediate”), APLD ChronoScale HoldCo LLC, a Delaware limited liability company and a wholly owned subsidiary of APLD Intermediate (“Contributor”), each a wholly owned direct or indirect subsidiary of Applied Digital Corporation, a Nevada corporation (“APLD”), and Applied Digital Cloud Corporation, a Nevada corporation, which at the time of the Closing (as defined below), will be a wholly owned subsidiary of Contributor (“Cloud”)
View on SEC.gov

Browse all equity issuances →

EKSO BIONICS HOLDINGS, INC. filing history →

Source: SEC EDGAR
accession 0001437749-26-004205
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.